Get the Stockscreener App
4.35
4.19%
-0.19
Sintx Technologies Inc stock is traded at $4.35, with a volume of 97,415.
It is down -4.19% in the last 24 hours and up +45.48% over the past month.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
See More
Previous Close:
$4.54
Open:
$4.66
24h Volume:
97,415
Relative Volume:
0.13
Market Cap:
$12.00M
Revenue:
$1.23M
Net Income/Loss:
$-8.26M
P/E Ratio:
-1.1231
EPS:
-3.8732
Net Cash Flow:
$-14.65M
1W Performance:
-21.05%
1M Performance:
+45.48%
6M Performance:
+34.26%
1Y Performance:
+25.36%
1-Day Range:
$4.2001
$4.66
1-Week Range:
$3.91
$4.80
52-Week Range:
$1.71
$8.5961
Sintx Technologies Inc Stock (SINT) Company Profile
Name
Sintx Technologies Inc
Sector
Industry
Phone
801-839-3516
Address
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Compare SINT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
4.35 | 12.03M | 1.23M | -8.26M | -14.65M | -3.8732 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Sintx Technologies Inc Stock (SINT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-19 | Initiated | Ascendiant Capital Markets | Buy |
Sintx Technologies Inc Stock (SINT) Latest News
Real time scanner hits for Sintx Technologies Inc. explainedQuarterly Growth Report & Real-Time Market Sentiment Reports - Newser
SINTX Technologies to Present at the H.C. Wainwright 27th - GlobeNewswire
Biomedical Ceramics Innovator SINTX Technologies to Showcase Silicon Nitride Platform at Global Investment Event - Stock Titan
Sintx Technologies Enters Inducement Agreement for $3.8M - TipRanks
Sintx Technologies enters inducement agreement for 1.1 million shares - MarketScreener
SALT LAKE CITYSINTX Technologies raises $3.8 million through warrant exercise By Investing.com - Investing.com South Africa
Is Sintx Technologies Inc. stock bottoming outWeekly Stock Recap & Growth Focused Entry Point Reports - Newser
Trend analysis for Sintx Technologies Inc. this weekWeekly Stock Report & Momentum Based Trading Ideas - Newser
Sintx Technologies Inc. Inches Toward Key Resistance — Will It Break2025 Market Trends & Weekly Top Performers Watchlists - beatles.ru
Is Sintx Technologies Inc. stock risky to hold nowLong Setup & Fast Moving Stock Watchlists - beatles.ru
What candlestick patterns are forming on Sintx Technologies Inc.Swing Trade & Safe Investment Capital Preservation Plans - Newser
Sintx Technologies Inc. recovery potential after sell off2025 Market Overview & Fast Moving Stock Trade Plans - Newser
Volume spikes in Sintx Technologies Inc. stock – what they meanWeekly Trade Review & Community Consensus Stock Picks - Newser
SINTX Technologies (SINT) Secures $3.8 Million Through Warrant E - GuruFocus
Order flow analysis tools used on Sintx Technologies Inc.Index Update & Stock Portfolio Risk Management - Newser
SINTX Technologies (SINT) Secures Key Patent for Antipathogenic Materials - GuruFocus
SINTX Technologies, Inc. Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent - MarketScreener
SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds - GlobeNewswire
$3.8 Million Capital Raise: SINTX Technologies Completes Warrant Exercise with New $4.79 Warrants - Stock Titan
Screener Results Flag Sintx Technologies Inc. as OversoldQuarterly Risk Review & Safe Capital Preservation Plans - beatles.ru
SINTX Technologies secures patent for antipathogenic materials - Investing.com
SINTX Technologies Achieves Patent Allowance for Antipathogenic Fibrous Materials in Infection-Prevention Market - Quiver Quantitative
99.97% Pathogen Reduction: SINTX's New Patent Could Transform $30B Healthcare Infection Prevention Market - Stock Titan
Sintx Technologies Inc.’s volatility index tracking explained2025 Volatility Report & Safe Entry Momentum Tips - Newser
What to expect from Sintx Technologies Inc. in the next 30 daysInsider Buying & Expert-Curated Trade Recommendations - Newser
Chart based analysis of Sintx Technologies Inc. trendsJuly 2025 PostEarnings & Weekly Top Gainers Trade List - Newser
Is this a good reentry point in Sintx Technologies Inc.July 2025 PreEarnings & AI Enhanced Trade Execution Alerts - Newser
Analyzing Sintx Technologies Inc. with risk reward ratio charts2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - Newser
Sintx Technologies Inc. stock chart pattern explainedQuarterly Growth Report & Expert Approved Momentum Ideas - Newser
How to manage a losing position in Sintx Technologies Inc.Weekly Gains Report & Community Trade Idea Sharing - Newser
Is Sintx Technologies Inc. still worth holding after the dipJuly 2025 Closing Moves & Short-Term Trading Alerts - Newser
Is Sintx Technologies Inc. stock a growth or value playWeekly Trend Recap & Accurate Technical Buy Alerts - Newser
Biotech And AI Play Starring Roles In Market Moves - Finimize
Will Sintx Technologies Inc. benefit from government policyJuly 2025 Levels & Fast Gain Swing Trade Alerts - خودرو بانک
Does Sintx Technologies Inc. stock reflect fundamentalsMarket Performance Report & Daily Technical Stock Forecast Reports - خودرو بانک
Sintx Technologies' Strategic CFO Appointment and Its Implications for Growth and Capital Allocation - AInvest
Is Sintx Technologies Inc. showing signs of accumulationMarket Performance Report & Stock Portfolio Risk Control - Newser
Sintx Technologies Names Trask Chief Financial Officer - 富途牛牛
SINTX Technologies Appoints Kevin Trask as CFO - AInvest
What is Sintx Technologies Inc. s revenue forecastWeekly Earnings Recap & Stock Timing and Entry Methods - خودرو بانک
Sintx Technologies Appoints New CFO Kevin Trask - TipRanks
Smart tools for monitoring Sintx Technologies Inc.’s price actionBond Market & Capital Efficiency Focused Ideas - Newser
What’s the profit margin of Sintx Technologies Inc.2025 Major Catalysts & Reliable Price Breakout Alerts - خودرو بانک
what data driven models say about sintx technologies inc.’s futureMarket Rally & Daily Stock Trend Watchlist - Newser
SINTX Technologies, Inc. Appoints Kevin Trask as Chief Financial Officer, Effective September 4, 2025 - MarketScreener
Using RSI to spot recovery in Sintx Technologies Inc.Earnings Summary Report & Risk Managed Investment Signals - Newser
Does Sintx Technologies Inc. stock have upside surprise potentialJuly 2025 Chart Watch & High Conviction Buy Zone Picks - خودرو بانک
Why Sintx Technologies Inc. stock attracts strong analyst attention2025 Earnings Surprises & Daily Entry Point Trade Alerts - Newser
Sintx Technologies Inc Stock (SINT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sintx Technologies Inc Stock (SINT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Honigblum Gregg R. | Chief Investment Officer |
Aug 26 '25 |
Buy |
3.70 |
50,000 |
185,000 |
64,000 |
| Olson Eric K. | President and CEO |
Aug 22 '25 |
Buy |
3.58 |
10,475 |
37,470 |
24,975 |
| Anderson Mark Lewis | Director |
Jun 18 '25 |
Buy |
3.30 |
10,000 |
33,000 |
15,000 |
| Anderson Mark Lewis | Director |
Apr 24 '25 |
Buy |
2.36 |
5,000 |
11,800 |
5,000 |
| Honigblum Gregg R. | Chief Strategy Officer |
Apr 22 '25 |
Buy |
1.79 |
4,000 |
7,160 |
14,000 |
| Olson Eric K. | President and CEO |
Apr 23 '25 |
Buy |
1.94 |
14,264 |
27,680 |
14,500 |
| Olson Eric K. | President and CEO |
Apr 22 '25 |
Buy |
1.73 |
236 |
408 |
236 |
| Honigblum Gregg R. | Chief Strategy Officer |
Apr 22 '25 |
Buy |
1.77 |
10,000 |
17,666 |
10,000 |
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):